R.PR
REGISTERED-PRINCIPAL REGISTER
16/11/2021
Voltar para busca
Dado oficial do USPTO
SPLENDRIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
14
Atualização mais recente
16/11/2021
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
17/12/2020
Data de registro
16/11/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
16/11/2021
Última transação
16/11/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
5
Tipo de titular
99
Localização do titular
Shenzhen, Guangdong, CN
Examinador
MURRAY, GEORGE WILLIAM
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the literal element "SPLENDRIS" in stylized font.
Titulares e representantes
Titulares
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.
Representantes
Nazly Aileen Bayramoglu BAYRAMOGLU LAW OFFICES LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Chemico-pharmaceutical preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposesfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Medicines for human purposefor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Medicated Trochesfor the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparationswhich are used for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; Medicinal herbal preparationsfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Biochemical medicinesfor treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseasesPharmaceutical preparations for the treatment of heart rhythm disordersSynthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical usebeverages and food in the nature of vitaminproteinmineralslecithinglucoseamino acidfolic acidfruit juicefruit oilhoneyseaweed gluefish oilcod-liver oilcubiloserestorativesplant fibrenutrition powdernutrient capsulenutrient tabletsmineral food-supplements used for treating diseases of cardiovascular systemfor treating diseases of cerebrovascular systemfor use in haematologydermatologyophthalmology and gastroenterologyanti-infectivesantitumor drugsfor treating metabolic diseasesfor treating nervous system diseasesfor treating diseases of respiratory systemdigestive systemendocrine systemimmune system and musculo-skeletal systemfor treating hypersensitivity diseases; Drugs for medical purposesPharmaceutical products for the prevention and treatment of disorders of the nervous systemthe immune systemthe cardiovascular systemthe cerebrovascular systemthe metabolic systemthe respiratory systemthe musculo-skeletal systemdigestive systemendocrine systemfor the treatment of infective diseasesfor use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders
Publicações
Histórico de despachos e eventos da marca no USPTO.
14 publicações encontradas
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/08/2021
PUBO
PUBLISHED FOR OPPOSITION
31/08/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
28/07/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
22/07/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/07/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/07/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/06/2021
GNRT
NON-FINAL ACTION E-MAILED
16/06/2021
CNRT
NON-FINAL ACTION WRITTEN
16/06/2021
DOCK
ASSIGNED TO EXAMINER
11/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/02/2021
NWAP
NEW APPLICATION ENTERED
21/12/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SPLENDRIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.